Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction

Nature Immunology

Volumn 7, Issue 12, 2006, Pages 1334-1342

  Welte, Stefan ^a   Kuttruff, Sabrina ^a   Waldhauer, Inja ^a   Steinle, Alexander ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LECTIN RECEPTOR; PROTEIN P80; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL TYPE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE ACTIVATION; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; RODENT;

ANIMALS; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOBLOTTING; INTERFERON TYPE II; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MONOCYTES; RECEPTOR CROSS-TALK; RECEPTORS, IMMUNOLOGIC; SURFACE PLASMON RESONANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845211608     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1402     Document Type: Article

References (44)

1. Trinchieri, G. Biology of natural killer cells. Adv. Immunol. 47, 187-376 (1989).
2. Karre, K. NK cells, MHC class I molecules and the missing self. Scand. J. Immunol. 55, 221-228 (2002).
3. Lanier, L.L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
4. Raulet, D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat. Immunol. 5, 996-1002 (2004).
5. Degli-Esposti, M.A. & Smyth, M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5, 112-124 (2005).
6. H1 priming. Nat. Immunol. 5, 1260-1265 (2004).
7. Ferlazzo, G. et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351 (2002).
8. Fernandez, N.C. et al. Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5, 405-411 (1999).
9. Gerosa, F. et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195, 327-333 (2002).
10. Piccioli, D., Sbrana, S., Melandri, E. & Valiante, N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195, 335-341 (2002).
11. Baratin, M. et al. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 102, 14747-14752 (2005).
12. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173, 6418-6426 (2004).
13. Moretta, A. et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223 (2001).
14. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729 (1999).
15. Roda-Navarro, P. et al. Human KLRF1, a novel member of the killer cell lectin-like receptor gene family: Molecular characterization, genomic structure, physical mapping to the NK gene complex and expression analysis. Eur. J. Immunol. 30, 568-576 (2000).
16. Vitale, M. et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31, 233-242 (2001).
17. Yokoyama, W.M. & Plougastel, B.F. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3, 304-316 (2003).
18. Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123-133 (2001).
19. Raulet, D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3, 781-790 (2003).
20. Vivier, E., Tomasello, E. & Paul, P. Lymphocyte activation via NKG2D: towards a new paradigm in immune recognition? Curr. Opin. Immunol. 14, 306-311 (2002).
21. Oppenheim, D.E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6, 928-937 (2005).
22. Smyth, M.J. et al. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202, 583-588 (2005).
23. Biassoni, R. et al. Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: Monitoring of NK cell function during simian HIV infection. J. Immunol. 174, 5695-5705 (2005).
24. Mavilio, D. et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 106, 1718-1725 (2005).
25. bright subset. Blood 97, 3146-3151 (2001).
26. Carlyle, J.R. et al. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc. Natl. Acad. Sci. USA 101, 3527-3532 (2004).
27. Iizuka, K., Naidenko, O.V., Plougastel, B.F., Fremont, D.H. & Yokoyama, W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat. Immunol. 4, 801-807 (2003).
28. Aldemir, H. et al. Cutting edge: Lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 175, 7791-7795 (2005).
29. Rosen, D.B. et al. Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 175, 7796-7799 (2005).
30. Hamann, J., Montgomery, K.T., Lau, S., Kucherlapati, R. & van Lier, R.A. AICL: A new activation-induced antigen encoded by the human NK gene complex. Immunogenetics 45, 295-300 (1997).
31. ++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542 (2002).
32. Bouchon, A., Dietrich, J. & Colonna, M. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J. Immunol. 164, 4991-4995 (2000).
33. Pende, D. et al. Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: Relevance for natural killer-dendritic cell interaction. Blood 107, 2030-2036 (2006).
34. LeNaour, F. et al. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 276, 17920-17931 (2001).
35. Shiow, L.R. et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540-544 (2006).
36. Vankayalapati, R. et al. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175, 4611-4617 (2005).
37. Li, P. et al. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat. Immunol. 2, 443-451 (2001).
38. Korbel, D.S., Newman, K.C., Almeida, C.R., Davis, D.M. & Riley, E.M. Heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 175, 7466-7473 (2005).
39. Zhang, R., Zheng, X., Li, B., Wei, H. & Tian, Z. Human NK cells positively regulate γδ T cells in response to Mycobacterium tuberculosis. J. Immunol. 176, 2610-2616 (2006).
40. Radsak, M.P. et al. The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. Blood 101, 2810-2815 (2003).
41. Welte, S.A. et al. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Eur. J. Immunol. 33, 194-203 (2003).
42. Aida, Y. & Pabst, M.J. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods 132, 191-195 (1990).
43. Alter, G., Malenfant, J.M. & Altfeld, M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294, 15-22 (2004).
44. Waldhauer, I. & Steinle, A. Proteolytic release of soluble UL16-binding protein 2 from tumor cells. Cancer Res. 66, 2520-2526 (2006).